Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India

Abdulsalim, Suhaj, Unnikrishnanz, Mazhuvancherry Kesavan, Manu, Mohan K, Alsahali, Saud, Alrasheedy, Allan A, Martin, Antony P ORCID: 0000-0003-4383-6038, Godman, Brian ORCID: 0000-0001-6539-6972 and Alfadl, Abubakr A
(2020) Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India. PHARMACOECONOMICS-OPEN, 4 (2). pp. 331-342.

[img] Text
Accepted for publication - Abdulsalim et al.docx - Author Accepted Manuscript

Download (311kB)


<h4>Background</h4>Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality, especially in low- and middle-income countries (LMICs) such as India. Medicine costs are a key issue in LMICs, with typically high patient co-payments. In addition, pharmacists are underutilised in LMICs, including India. However, pharmacist-led educational interventions may improve the care of patients with COPD, as well as reduce medicine costs. Consequently, the objective of this study was to assess the effectiveness of a pharmacist-led intervention in reducing medicine costs.<h4>Methodology</h4>We assessed the impact of a pharmacist intervention on direct medicine costs in COPD patients (medicine costs and pharmacist time) in a randomised controlled study involving an intervention and control group, conducted at a tertiary care teaching hospital in India.<h4>Results</h4>The 6-monthly cost of medicines at baseline increased with disease severity, from a maximum of US$29.46 for those with mild COPD to US$63.28 for those with very severe COPD. Substantial savings in medical costs were achieved with the pharmacist-led programme, to a maximum of US$20.49 over 6 months for very severe patients. This equates to a reduction of 30.6% in medicine costs (p < 0.001), reduced to 26.1% when pharmacists' time (US$3.00/patient) was included.<h4>Conclusion</h4>There could be a key role for pharmacists as educators for COPD patients in LMICs, to improve care and reduce costs, including patient co-payments.

Item Type: Article
Uncontrolled Keywords: Clinical Trials and Supportive Activities, Clinical Research, Comparative Effectiveness Research, Lung, Health Services, Chronic Obstructive Pulmonary Disease, Respiratory, 3 Good Health and Well Being
Depositing User: Symplectic Admin
Date Deposited: 11 Jul 2019 14:38
Last Modified: 17 Mar 2024 04:35
DOI: 10.1007/s41669-019-0172-x
Related URLs: